VeinViewer is the only device of its kind to have a positive impact on a patient’s experience due to improved peripheral IV insertion
MEMPHIS, Tennessee (PRWEB) May 13, 2016
Christie Medical Holdings will be displaying its industry leading lineup of VeinViewer near-infrared, vein finder technology at the 2016 National Teaching Institute and Critical Care Exposition, May 16-19 at the New Orleans Ernest M. Morial Convention Center.
Critical care nurses and physicians from all over the world will participate in courses to learn how VeinViewer technology can help reduce the time needed for IV insertion and reduce the use of PICCs by up to 30 percent. Clinically proven to increase first stick success rates by up to 100 percent, VeinViewer assessment allows clinicians to make a more informed choice when starting an IV catheter. VeinViewer uses near-infrared light to create a real-time digital image of a patient’s veins on their skin and aids in determining the point of insertion in venipuncture procedures by locating valves and bifurcations.
“VeinViewer is the only device of its kind to have a positive impact on a patient’s experience due to improved peripheral IV insertion,” says George Pinho, president, Christie Medical Holdings. “With ninety percent of hospital patients requiring venipuncture for a blood draw or IV insertion, we’re eager to demonstrate how VeinViewer can improve the quality of care for patients, especially those with difficult venous access. It’s why so many of America’s top hospitals have added VeinViewer imaging to their IV practice.”
Christie Medical Holdings is offering programs for nurses and other clinicians to receive Continuing Education Recognition Points (CERPs) at three ExpoEd Sessions: First Stick Success: Technology Makes a Significant Impact; Overcoming Vascular Access Challenges; and Fewer Sticks and Fewer PICCs. ExpoEd sessions will be held in the Christie Medical booth, number 3816.
To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex please visit http://www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit http://www.christiemed.com.
For cautions associated to Christie Medical Holdings products, please visit http://www.christiemed.com/cautions.
Follow us on Twitter @christiemed
"Christie" is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.